Recommendations
by
Cheema, Karan et al via METAPHI
Release Date
2023
Geography
Canada
Language of Resource
English
Full Text Available
Yes
Open Access / OK to Reproduce
No
Peer Reviewed
No
Findings/Key points
Bringing together published evidence and both clinical and experiential expertise, these recommendations are intended to guide prescribers in the use of slow-release oral morphine (SROM, brand name Kadian) as opioid agonist therapy (OAT). There is also a plain language summary of the recommendations, intended for patients interested in learning about SROM as OAT.
File
Recommendations for SROM.pdf
(316.82 KB)
SROM_PlainLanguage.pdf
(95.51 KB)
Keywords
Carries/take-home doses
Clinical guidance
Hospitals
Substitution/OAT
Withdrawal